Statistical Analysis and Implications of FDA Drug Inspection Observations in Fiscal Year 2019

Statistical Analysis and Implications of FDA Drug Inspection Observations in Fiscal Year 2019

GE Yuanyuan, ZHANG Jingchen, CHEN Guiliang

PDF(6655 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(6655 KB)

Chinese Journal of Pharmaceuticals ›› 2020, Vol. 51 ›› Issue (02) : 276-283. DOI: 10.16522/j.cnki.cjph.2020.02.020

Pharmaceutical Management & Information

Statistical Analysis and Implications of FDA Drug Inspection Observations in Fiscal Year 2019

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 51(02): 276-283 https://doi.org/10.16522/j.cnki.cjph.2020.02.020

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(6655 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉